FDA 483 - Dr. Reddy's Laboratories Ltd. - May 17, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Dr. Reddy's Laboratories Ltd. in Duvvada, India, a parenteral drug manufacturer, revealed significant deficiencies in preventing microbial contamination of sterile drug products. Observations included a lack of aseptic transfer procedures, inadequate smoke studies, and insufficient root cause analysis for fungal excursions. Additionally, the firm failed to properly clean, maintain, and sanitize equipment and storage tanks, leading to potential contamination risks.
ID · 9ef33f8d-ed05-445d-b810-f8f28ba9355c